Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by sghorbon Nov 25, 2020 7:16pm
870 Views
Post# 31975435

Never felt better

Never felt betterI already sold all my shares, last week right after the NR and price drop. 

We got some of the best news in the history of this company, and the stock didn't even fart. It actually went lower. Something I have only seen a few times in MY ENTIRE LIFE. 

What more news do you want? lol

I'm not saying this stock doesn't  have potential. But what is the point of staying here long when the stock will barely move. Don't worry you will have plenty of oppurtunities to buy in again. This stock is not the type of stock that reacts well. We saw proof. 

They say price target is 4$. Yes maybe, but not anytime soon. And even so, what do you think, it will jump there in a few weeks? come on lol. get real.

If this stock even reaches 1$ by Q1 2021, that is something I will consider good (for this company). But keep in mind this stock is not profitable, they are actually spending all the money they are getting. Yes I know that is a good thing, but not to share holders who want some decent returns within the next 6 months. Aristotle will need tons of money to market. Where is that money coming from? all this covid testing. 

Sold last week, and already up 15% in another stock this week. Anyway, just my 2 cents. 

I know some of you will get emotional about this. As expected. I'll buy in again when the SP is more reactive to positive news. I won't miss the train. Not the way this stock reacts. 
<< Previous
Bullboard Posts
Next >>